We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CXP
876
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $368K | 0.04% |
16,331
-23,853
| -59% | -$516K |
|
877
Voyager Therapeutics
VYGR
$198M
| $367K | 0.04% |
19,178
-15,022
| -44% | -$196K |
|
878
Valvoline
VVV
$4.51B
| $366K | 0.04% |
+19,695
| New | +$390K |
|
|
GWB
879
DELISTED
Great Western Bancorp, Inc.
GWB
| $365K | 0.04% |
+11,551
| New | +$401K |
|
|
HOLX
880
DELISTED
Hologic
HOLX
| $363K | 0.04% |
+7,499
| New | +$338K |
|
|
RYZ
881
Ryerson Holding Corp
RYZ
$1.46B
| $363K | 0.04% |
42,457
+3,958
| +10% | +$30.7K |
|
882
Peabody Energy
BTU
$2.9B
| $362K | 0.04% |
+12,774
| New | +$403K |
|
883
Oil States International
OIS
$491M
| $362K | 0.04% |
+21,332
| New | +$361K |
|
884
Snap-on
SNA
$21.5B
| $362K | 0.04% |
+2,315
| New | +$368K |
|
885
Zions Bancorporation
ZION
$10.3B
| $362K | 0.04% |
+7,981
| New | +$381K |
|
|
FSCT
886
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $362K | 0.04% |
+8,646
| New | +$310K |
|
887
Kaiser Aluminum
KALU
$3.02B
| $361K | 0.04% |
+3,449
| New | +$351K |
|
|
KREF
888
KKR Real Estate Finance Trust
KREF
$499M
| $361K | 0.04% |
18,030
-17,515
| -49% | -$354K |
|
889
Mastercard
MA
$493B
| $361K | 0.04% |
1,535
-5,503
| -78% | -$1.18M |
|
890
Lindblad Expeditions
LIND
$2.22B
| $359K | 0.04% |
23,555
-5,117
| -18% | -$69.6K |
|
|
OSG
891
DELISTED
Overseas Shipholding Group Inc.
OSG
| $358K | 0.04% |
156,230
-63,700
| -29% | -$127K |
|
|
CDK
892
DELISTED
CDK Global, Inc.
CDK
| $358K | 0.04% |
6,087
-236
| -4% | -$12.9K |
|
|
REV
893
DELISTED
Revlon, Inc.
REV
| $358K | 0.04% |
+18,463
| New | +$447K |
|
894
Pacific Biosciences
PACB
$370M
| $357K | 0.04% |
+49,403
| New | +$357K |
|
895
Rapid7
RPD
$773M
| $356K | 0.04% |
+7,029
| New | +$301K |
|
896
Whirlpool
WHR
$2.82B
| $355K | 0.04% |
+2,674
| New | +$353K |
|
897
Cushman & Wakefield Ltd
CWK
$3.25B
| $353K | 0.04% |
+19,819
| New | +$342K |
|
898
Mid-America Apartment Communities
MAA
$15.7B
| $353K | 0.04% |
+3,225
| New | +$332K |
|
899
Mistras Group
MG
$512M
| $353K | 0.04% |
+25,527
| New | +$382K |
|
900
J. Jill
JILL
$283M
| $352K | 0.04% |
12,820
-12,834
| -50% | -$328K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.